Table 1.
Demographic and Clinical Characteristics of Study Participants according to Fatigue Severity Score
| Characteristic | Fatigue Severity Score <4 n = 24 | Fatigue Severity Score ≥4 n = 36 | Total n = 60 | P-value |
|---|---|---|---|---|
| Age, mean ± SD | 56.3 ± 13.5 | 54.3 ± 12.3 | 55.1 ± 12.7 | 0.56 |
| Females, n (%) | 8 (33.3) | 13 (36.1) | 21 (35.0) | 0.83 |
| Location of residence, n (%) | 0.29 | |||
| urban | 16 (66.7) | 19 (52.8) | 35 (58.3) | |
| semi-urban/rural | 8 (33.3) | 17 (47.2) | 25 (41.7) | |
| Educational status, n (%) | 0.07 | |||
| None | 0 (0.0) | 3 (8.3) | 3 (5.0) | |
| Primary | 8 (33.4) | 20 (55.6) | 28 (46.7) | |
| Secondary | 11 (45.8) | 7 (19.4) | 18 (30.0) | |
| Tertiary | 5 (20.8) | 6 (16.7) | 11 (18.3) | |
| Stroke type | 0.80 | |||
| Ischemic | 18 (75.0) | 28 (77.8) | 46 (76.7) | |
| Hemorrhagic | 6 (25.0) | 8 (22.2) | 14 (23.3) | |
| Diabetes Mellitus, n (%) | 1 (4.2) | 14 (38.9) | 15 (25.0) | 0.002** |
| Systolic BP, mean ± SD | 153.7 ± 21.8 | 137.3 ± 27.8 | 143.8 ± 26.6 | 0.02 |
| Diastolic BP, mean ± SD | 94.8 ± 13.4 | 87.7 ± 16.4 | 90.5 ± 15.5 | 0.08 |
| Waist circumference, mean ± SD | 93.3 ± 12.4 | 91.0 ± 11.6 | 91.9 ± 11.9 | 0.48 |
| Body Mass Index, mean ± SD | 27.7 ± 5.2 | 26.2 ± 5.6 | 26.8 ± 5.5 | 0.33 |
| Barthels Index, mean ± SD | 75.4 ± 22.6 | 78.3 ± 24.1 | 77.2 ± 23.4 | 0.64 |
| NIHSS Score, mean ± SD | 4.7 ± 2.8 | 4.6 ± 3.5 | 4.7 ± 3.2 | 0.94 |
| HDRS Score, mean ± SD | 10.7 ± 5.8 | 10.9 ± 5.7 | 10.9 ± 5.7 | 0.90 |
| # Antihypertensive medications, mean ± SD | 2.9 ± 1.0 | 2.4 ± 0.9 | 2.6 ± 1.0 | 0.09 |
| Methyldopa, n (%) | 4 (16.7) | 11 (30.6) | 15 (25.0) | 0.22 |
| Angiotensin Receptor Blocker, n (%) | 14 (58.3) | 19 (52.8) | 33 (55.0) | 0.67 |
| Fluoxetine, n (%) | 9 (37.5) | 16 (44.4) | 25 (41.7) | 0.59 |
| Statins, n (%) | 21 (87.5) | 22 (61.1) | 43 (71.7) | 0.03* |
| Antiplatelets, n (%) | 15 (62.5) | 16 (44.4) | 31 (51.7) | 0.17 |
| Multivitamins, n (%) | 3 (12.5) | 8 (22.2) | 11 (18.3) | 0.34 |